Mar 2, 2026 10:38AM
Mar 2, 2026 04:55AM
Feb 23, 2026 05:31PM
Feb 12, 2026 01:54PM
Feb 12, 2026 10:03AM
Feb 11, 2026 04:01PM
Jan 20, 2026 05:30AM Ascendis Pharma (ASND) PT Raised to $250 at RBC Capital
Jan 12, 2026 08:26AM
Jan 9, 2026 06:01PM
Jan 9, 2026 07:10AM
Jan 8, 2026 04:04PM
Jan 8, 2026 04:01PM
Nov 26, 2025 07:00AM
Nov 26, 2025 06:48AM Ascendis Pharma's (ASND) PDUFA Disclosure Removes Near-Term Stock Upside - Stifel
Nov 25, 2025 06:15PM
Nov 24, 2025 08:53AM
Nov 17, 2025 04:01PM
Nov 17, 2025 04:01PM
Nov 13, 2025 04:04AM
Nov 12, 2025 04:01PM
Oct 8, 2025 04:01PM Ascendis submits European approval application for achondroplasia drug
Oct 8, 2025 04:01PM
Sep 23, 2025 08:59AM
Sep 8, 2025 09:46AM
Aug 8, 2025 08:40AM
Aug 7, 2025 04:01PM
Jun 25, 2025 10:13AM
Jun 2, 2025 12:02PM Ascendis Pharma (ASND) PT Raised to $201 at BofA Securities
Jun 2, 2025 08:01AM
Jun 2, 2025 08:00AM
May 1, 2025 04:01PM
Feb 15, 2025 10:00PM
Feb 13, 2025 08:32AM
Feb 13, 2025 07:15AM
Feb 12, 2025 04:01PM Ascendis Pharma Reports Fourth Quarter and Full Year 2024 Financial Results
Jan 12, 2025 05:00PM
Dec 12, 2024 04:02PM
Dec 12, 2024 04:01PM
Aug 21, 2024 06:21AM
Aug 12, 2024 01:43PM
Jun 25, 2024 05:36AM
Jun 12, 2024 05:58AM BofA Securities Reiterates Buy Rating on Ascendis Pharma (ASND)
May 30, 2024 04:07PM
May 15, 2024 04:41PM
May 14, 2024 02:32PM
May 14, 2024 02:31PM
May 13, 2024 08:33AM
May 13, 2024 08:30AM
May 9, 2024 08:32AM Ascendis Pharma (ASND) to Present Latest Clinical and Quality-of-Life Data for TransCon PTH-Treated Adults with Chronic Hypoparathyroidism
May 9, 2024 08:30AM

14,982 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All